HomeInsightsStock Comparison

Krebs Biochemicals Industries Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Krebs Biochemicals Industries Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: Apr 25, 2025

Key Highlights

  • The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 79.1 as of 25 Apr 15:30.
  • The P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 53.2 on March 2024 . This represents a CAGR of 10.29% over 5 years.
  • The Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 88030 crore on March 2024 . This represents a CAGR of 21.42% over 5 years.
  • The revenue of Krebs Biochemicals & Industries Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Torrent Pharmaceuticals Ltd for the Dec '24 is ₹ 2842 crore as compare to the Sep '24 revenue of ₹ 2873 crore. This represent the decline of -1.08%.
  • The ebitda of Krebs Biochemicals & Industries Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Torrent Pharmaceuticals Ltd for the Dec '24 is ₹ 947 crore as compare to the Sep '24 ebitda of ₹ 923 crore. This represent the growth of 2.6%.
  • The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 503 crore over 7 quarters. This represents a CAGR of 17.73% .
  • The Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 69.83 % on March 2024 . This represents a CAGR of 3.89% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
  • Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.
  • Apart from this, it has a modern and well-equipped state-of-the-art R&D Centre at Bhat near Ahmedabad, built with an investment of US $ 40 million.

Krebs Biochemicals & Industries Ltd News Hub

News

Krebs Biochemicals & Industries to convene board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

15 Jan 2025 15:28

News

Krebs Biochemicals & Industries Ltd leads losers in 'B' group

Uflex Ltd, Raghav Productivity Enhancers Ltd, Ruby Mills Ltd and Shree Rama Multi-Tech Ltd...

Read more

28 Nov 2024 14:45

News

Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

Ruby Mills Ltd, 3P Land Holdings Ltd, Godavari Biorefineries Ltd and RPP Infra Projects Lt...

Read more

26 Nov 2024 12:15

News

Krebs Biochemicals & Industries to conduct board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

29 Oct 2024 14:40

News

Krebs Biochemicals & Industries schedules AGM

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of th...

Read more

09 Sep 2024 10:11

News

Krebs Biochemicals & Industries to announce Quarterly Result

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

22 Jul 2024 10:35

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals announces resignation of ED (Strategic Planning)

Torrent Pharmaceuticals announced that Pranav Mehta, Executive Director (Strategic Plannin...

Read more

27 Feb 2025 18:47

News

Torrent Pharmaceuticals Ltd rises for third consecutive session

Torrent Pharmaceuticals Ltd gained for a third straight session today. The stock is quotin...

Read more

07 Feb 2025 13:05

News

Torrent Pharmaceuticals Ltd slips for fifth straight session

Torrent Pharmaceuticals Ltd is down for a fifth straight session today. The stock is quoti...

Read more

04 Feb 2025 13:35

News

Torrent Pharma gains after Q3 PAT rises 14% YoY to Rs 503 cr

Revenue from operations grew 2.6% year on year (YoY) to Rs 2,762 crore in the quarter ende...

Read more

27 Jan 2025 14:33

News

Board of Torrent Pharmaceuticals recommends interim dividend

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

24 Jan 2025 17:25

News

Torrent Pharmaceuticals to declare Quarterly Result

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24...

Read more

15 Jan 2025 10:12

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Krebs Biochemicals & Industries Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Krebs Biochemicals & Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Krebs Biochemicals & Industries Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Krebs Biochemicals & Industries Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Krebs Biochemicals & Industries Ltd is 170 Cr while Market cap of Torrent Pharmaceuticals Ltd is 109,514 Cr

What are the key factors driving the stock performance of Krebs Biochemicals & Industries Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Krebs Biochemicals & Industries Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krebs Biochemicals & Industries Ltd and Torrent Pharmaceuticals Ltd?

As of April 25, 2025, the Krebs Biochemicals & Industries Ltd stock price is INR ₹79.1. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3235.95.

How do dividend payouts of Krebs Biochemicals & Industries Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Krebs Biochemicals & Industries Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions